<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="41873" whole_study_id="19617" phs="001252" v="2" createDate="2021-05-11T10:21:35-05:00" completedByGPADate="2021-06-09T13:20:52-05:00" modDate="2022-01-25T16:16:27-05:00" maxParentChildStudyModDate="2022-01-25T16:16:27-05:00" handle="ECLIPSE_COPD" num_participants="2746"><StudyInfo accession="phs001252.v2" parentAccession="phs001252.v2"><BioProject id="PRJNA354105" entrez_id="354105" type="bp_admin_access"/><BioProject id="PRJNA354106" entrez_id="354106" type="bp_data_submission"/><StudyNameEntrez>Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="Yes"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="cloud_for_sequence"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="geo"/><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>protomic_metabolomic</StudyType><StudyType>snp_array</StudyType><StudyType>geo</StudyType><StudyType>array_derived_genotypes</StudyType><StudyType>analysis</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="EKS123" aid="2" auth="eRA" login="EKS123" fname="Edwin" mname="K" lname="Silverman" email="ED.SILVERMAN@CHANNING.HARVARD.EDU"><Role allow_direct_access="true">PI</Role><Organization>BRIGHAM AND WOMEN'S HOSPITAL</Organization></Person><Person nedid="0013114408" aid="1" auth="cit" login="ganw2" fname="Weiniu" mname="" lname="Gan" email="ganw2@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="VJC123" aid="2" auth="eRA" login="VJC123" fname="VINCENT" lname="CAREY" email="VJC123@CHANNING.HARVARD.EDU"><Role>PI_ASSIST</Role><Organization>BRIGHAM AND WOMEN'S HOSPITAL</Organization></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011552437" aid="1" auth="cit" login="jawang" fname="Zhen" mname="Yuan" lname="Wang" email="zhen.wang@nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The ECLIPSE Study (NCT00292552, SC0104960) was sponsored by GlaxoSmithKline.  ECLIPSE investigators included:  
Bulgaria: Y Ivanov, Pleven; K Kostov, Sofia. Canada: J Bourbeau, Montreal; M Fitzgerald, Vancouver; P Hern&#225;ndez, Halifax; K Killian, Hamilton; R Levy, Vancouver; F Maltais, Montreal; D O&#180;Donnell, Kingston. Czech Republic: J Krepelka, Praha. Denmark: J Vestbo, Hvidovre. The Netherlands: E Wouters, Horn. New Zealand: D Quinn, Wellington. Norway: P Bakke, Bergen, Slovenia: M Kosnik, Golnik. Spain: A Agusti, Jaume Sauleda, Palma de Mallorca. Ukraine: Y Feschenko, Kiev; V Gavrisyuk, Kiev; L Yashina, Kiev. UK: W MacNee, Edinburgh; D Singh, Manchester; J Wedzicha, London. USA: A Anzueto, San Antonio, TX; S Braman, Providence. RI; R Casaburi, Torrance CA; B Celli, Boston, MA; G Giessel, Richmond, VA; M Gotfried, Phoenix, AZ; G Greenwald, Rancho Mirage, CA; N Hanania, Houston, TX; D Mahler, Lebanon, NH; B Make, Denver, CO; S Rennard, Omaha, NE; C Rochester, New Haven, CT; P Scanlon, Rochester, MN; D Schuller, Omaha, NE; F Sciurba, Pittsburg, PA; A Sharafkhaneh, Houston, TX; T Siler, St Charles, MO; E Silverman, Boston, MA; A Wanner, Miami, FL; R Wise, Baltimore, MD; R ZuWallack, Hartford, CT.
Steering Committee: H. Coxson (Canada), C. Crim (GlaxoSmithKline, USA), L. Edwards (GlaxoSmithKline, USA), D. Lomas (UK), W. MacNee (UK), E. Silverman (USA), R. Tal Singer (Co-chair, GlaxoSmithKline, USA), J. Vestbo (Co-chair, Denmark), J. Yates (GlaxoSmithKline, USA). 
Scientific Committee: A. Agusti (Spain), P. Calverley (UK), B. Celli (USA), C. Crim (GlaxoSmithKline, USA), B. Miller (GlaxoSmithKline, USA), W. MacNee (Chair, UK), S. Rennard (USA), R. Tal-Singer (GlaxoSmithKline, USA), E. Wouters (The Netherlands), J. Yates (GlaxoSmithKline, USA).
</acknowledgement_statement><ic_specific_access_term>Use of this data is limited to studies of COPD and other smoking-related disorders. The full list of diseases or conditions for which smoking is considered to be a risk factor can be found at: www.copdgene.org/smoking-related-disorders. Use of the data includes methods development research (e.g., development of software or algorithms). The institutional certification assured that data submission was compliant with, and limited to, local and federal policies, and Massachusetts state law; To the extent possible, consideration was given to individuals and groups for subsequent data sharing and are reviewed by the National Institutes of Health&#8217;s Data Access Committees.</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access_timeout_extend" gsr_mode_label="Controlled-access (institution requested additional time)"/><ConsentGroup uid="2016" CGType="cg_class_DS" title="Disease-Specific (COPD and Smoking, MDS, RD)" name="DS-CS-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of the data must be related to COPD and Smoking and related disorders.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of this data is limited to studies of COPD and other smoking-related disorders. The full list of diseases or conditions for which smoking is considered to be a risk factor can be found at: www.copdgene.org/smoking-related-disorders. Use of the data includes methods development research (e.g., development of software or algorithms). The institutional certification assured that data submission was compliant with, and limited to, local and federal policies, and Massachusetts state law; To the extent possible, consideration was given to individuals and groups for subsequent data sharing and are reviewed by the National Institutes of Health&#8217;s Data Access Committees.</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="2016"><StudyTo study_uid="37911" name="NHLBI Big Data Analysis Heart Failure Challenge Data Collection" accession="phs001991.v1"><ConsentGroupTo uid="4656" name="DS-CS-MDS-RD"/></StudyTo></ConsentGroupLink></ConsentGroupLinks><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="14" name="completed_by_gpa" title="Completed by GPA"/></Study><Study uid="19617" whole_study_id="19617" phs="001252" v="1" p="1" createDate="2016-05-25T11:11:24-05:00" completedByGPADate="2016-05-27T13:07:43-05:00" modDate="2022-01-25T16:16:13-05:00" maxParentChildStudyModDate="2022-01-25T16:16:13-05:00" handle="ECLIPSE_COPD" num_participants="2746"><StudyInfo accession="phs001252.v1.p1" parentAccession="phs001252.v1.p1"><BioProject id="PRJNA354105" entrez_id="354105" type="bp_admin_access"/><BioProject id="PRJNA354106" entrez_id="354106" type="bp_data_submission"/><StudyNameEntrez>Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="Yes"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="cloud_for_sequence"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="geo"/><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>protomic_metabolomic</StudyType><StudyType>snp_array</StudyType><StudyType>geo</StudyType><StudyType>array_derived_genotypes</StudyType><StudyType>analysis</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="EKS123" aid="2" auth="eRA" login="EKS123" fname="Edwin" mname="K" lname="Silverman" email="ED.SILVERMAN@CHANNING.HARVARD.EDU"><Role allow_direct_access="true">PI</Role><Organization>BRIGHAM AND WOMEN'S HOSPITAL</Organization></Person><Person nedid="0013114408" aid="1" auth="cit" login="ganw2" fname="Weiniu" mname="" lname="Gan" email="ganw2@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="VJC123" aid="2" auth="eRA" login="VJC123" fname="VINCENT" lname="CAREY" email="VJC123@CHANNING.HARVARD.EDU"><Role>PI_ASSIST</Role><Organization>BRIGHAM AND WOMEN'S HOSPITAL</Organization></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011552437" aid="1" auth="cit" login="jawang" fname="Zhen" mname="Yuan" lname="Wang" email="zhen.wang@nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The ECLIPSE Study (NCT00292552, SC0104960) was sponsored by GlaxoSmithKline.  ECLIPSE investigators included:  
Bulgaria: Y Ivanov, Pleven; K Kostov, Sofia. Canada: J Bourbeau, Montreal; M Fitzgerald, Vancouver; P Hern&#225;ndez, Halifax; K Killian, Hamilton; R Levy, Vancouver; F Maltais, Montreal; D O&#180;Donnell, Kingston. Czech Republic: J Krepelka, Praha. Denmark: J Vestbo, Hvidovre. The Netherlands: E Wouters, Horn. New Zealand: D Quinn, Wellington. Norway: P Bakke, Bergen, Slovenia: M Kosnik, Golnik. Spain: A Agusti, Jaume Sauleda, Palma de Mallorca. Ukraine: Y Feschenko, Kiev; V Gavrisyuk, Kiev; L Yashina, Kiev. UK: W MacNee, Edinburgh; D Singh, Manchester; J Wedzicha, London. USA: A Anzueto, San Antonio, TX; S Braman, Providence. RI; R Casaburi, Torrance CA; B Celli, Boston, MA; G Giessel, Richmond, VA; M Gotfried, Phoenix, AZ; G Greenwald, Rancho Mirage, CA; N Hanania, Houston, TX; D Mahler, Lebanon, NH; B Make, Denver, CO; S Rennard, Omaha, NE; C Rochester, New Haven, CT; P Scanlon, Rochester, MN; D Schuller, Omaha, NE; F Sciurba, Pittsburg, PA; A Sharafkhaneh, Houston, TX; T Siler, St Charles, MO; E Silverman, Boston, MA; A Wanner, Miami, FL; R Wise, Baltimore, MD; R ZuWallack, Hartford, CT.
Steering Committee: H. Coxson (Canada), C. Crim (GlaxoSmithKline, USA), L. Edwards (GlaxoSmithKline, USA), D. Lomas (UK), W. MacNee (UK), E. Silverman (USA), R. Tal Singer (Co-chair, GlaxoSmithKline, USA), J. Vestbo (Co-chair, Denmark), J. Yates (GlaxoSmithKline, USA). 
Scientific Committee: A. Agusti (Spain), P. Calverley (UK), B. Celli (USA), C. Crim (GlaxoSmithKline, USA), B. Miller (GlaxoSmithKline, USA), W. MacNee (Chair, UK), S. Rennard (USA), R. Tal-Singer (GlaxoSmithKline, USA), E. Wouters (The Netherlands), J. Yates (GlaxoSmithKline, USA).
</acknowledgement_statement><ic_specific_access_term>Use of this data is limited to studies of COPD and other smoking-related disorders. The full list of diseases or conditions for which smoking is considered to be a risk factor can be found at: www.copdgene.org/smoking-related-disorders.  Use of the data includes methods development research (e.g., development of software or algorithms).  The institutional certification assured that data submission was compliant with, and limited to, local and federal policies, and Massachusetts state law; To the extent possible, consideration was given to individuals and groups for subsequent data sharing and are reviewed by the National Institutes of Health&#8217;s Data Access Committees.</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access_timeout_extend" gsr_mode_label="Controlled-access (institution requested additional time)"/><ConsentGroup uid="2016" CGType="cg_class_DS" title="Disease-Specific (Chronic Obstructive Pulmonary Disease, RD)" name="DS-COPD-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Chronic Obstructive Pulmonary Disease and related disorders.

</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="2016"><StudyTo study_uid="37911" name="NHLBI Big Data Analysis Heart Failure Challenge Data Collection" accession="phs001991.v1"><ConsentGroupTo uid="3888" name="DS-COPD-RD"/></StudyTo></ConsentGroupLink></ConsentGroupLinks><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>